NAD+ 500mg — Verification Report
From Aigil Research · Lot AG-NAD500 · Tested June 2026
VialTalk
NAD+ 500mg
Aigil Research
Score
89.6
Grade
B
Good
Lot AG-NAD500
Tested June 2026
Report ID
bcc5f307
Test
Method
Result
Status
PurityFull credit
HPLC
99.1%
Full credit
IdentityStrong
HPLC retention time
Consistent
Strong
ContentStrong
Gravimetric vs label claim
500 mg labeled · 510 mg tested
Strong
EndotoxinNot submitted
Not tested
Not tested
Not submitted
Heavy metalsNot submitted
Not tested
Not tested
Not submitted
SterilityNot submitted
Not tested
Not tested
Not submitted
Batch conformityNot submitted
Not tested
Not tested
Not submitted
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/aigil-research/coas/bcc5f307-43c2-467c-b95d-aed6d7326b33